Clinical Scorecard: Increased Microvascular Resistance from Angiography and HbA1c Levels as Predictors of Poor Outcomes in Diabetic STEMI Patients: A Multicenter Retrospective Analysis

At a Glance

Key Highlights

• Elevated AMR and HbA1c levels are independently associated with major adverse cardiovascular and cerebrovascular events (MACCEs).
• Patients with HbA1c ≥6.5% and AMR ≥250.5 mmHg·s/m have the highest risk of MACCEs.
• Nonlinear relationships exist between MACCEs and both HbA1c and AMR levels.
• Combined evaluation of AMR and HbA1c enhances risk stratification for MACCEs.
• Assessment of coronary microcirculatory function may improve long-term outcomes.

Guideline-Based Recommendations

Diagnosis

• STEMI is defined by complete occlusion of a coronary artery due to thrombus formation over an atherosclerotic plaque.

Management

• Patients must undergo percutaneous coronary intervention (PCI) for STEMI.

Monitoring & Follow-up

• Monitor HbA1c levels and AMR post-PCI to assess risk for MACCEs.

Risks

• Type 2 diabetes mellitus is a significant risk factor for adverse outcomes in STEMI patients.

Patient & Prescribing Data

Patients diagnosed with STEMI and type 2 diabetes mellitus.

Sustained optimization of glycemic control is important for improving clinical outcomes.

Clinical Best Practices

• Incorporate AMR assessment in the evaluation of STEMI patients with diabetes.
• Regularly monitor glycemic control in diabetic patients post-STEMI.

Related Resources & Content

• American College of Cardiology Guidelines for the Management of Patients with Acute Coronary Syndrome
• American Diabetes Association Diagnostic Criteria for T2DM